IRhythm Technologies Revenue 2015-2024 | IRTC

IRhythm Technologies revenue from 2015 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
IRhythm Technologies Annual Revenue
(Millions of US $)
2023 $493
2022 $411
2021 $323
2020 $265
2019 $215
2018 $147
2017 $99
2016 $64
2015 $36
2014 $22
IRhythm Technologies Quarterly Revenue
(Millions of US $)
2024-09-30 $148
2024-06-30 $148
2024-03-31 $132
2023-12-31 $133
2023-09-30 $125
2023-06-30 $124
2023-03-31 $111
2022-12-31 $113
2022-09-30 $104
2022-06-30 $102
2022-03-31 $92
2021-12-31 $82
2021-09-30 $85
2021-06-30 $81
2021-03-31 $74
2020-12-31 $79
2020-09-30 $72
2020-06-30 $51
2020-03-31 $64
2019-12-31 $59
2019-09-30 $55
2019-06-30 $52
2019-03-31 $48
2018-12-31 $43
2018-09-30 $38
2018-06-30 $35
2018-03-31 $31
2017-12-31 $29
2017-09-30 $25
2017-06-30 $24
2017-03-31 $21
2016-12-31 $19
2016-09-30 $17
2016-06-30 $16
2016-03-31 $13
2015-12-31
2015-09-30 $9
2015-06-30
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.362B $0.493B
iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Inspire Medical Systems (INSP) United States $5.276B 164.53
Hims & Hers Health (HIMS) United States $5.141B 130.72
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00